Pacroma XL Cream

Pacroma XL Cream

Pacroma XL Cream is a high-potency dermatological intervention containing Pimecrolimus, a specialized calcineurin inhibitor specifically engineered for the clinical management of atopic dermatitis (eczema) and chronic inflammatory skin dysregulation. Utilizing a unique “Immuno-Selective” delivery system, this formulation works by inhibiting the activation of T-cells and preventing the release of pro-inflammatory cytokines and mediators from mast cells. By neutralizing the biochemical triggers of intense pruritus (itching) and localized erythema, Pacroma XL effectively modulates the skin’s overactive immune response without the long-term risks associated with topical corticosteroids. This targeted biochemical action provides a decisive therapeutic response by reinforcing the structural integrity of the epidermal barrier and promoting sustained symptomatic remission.

Key Features

• Specifically formulated to target inflammatory cells without affecting the underlying collagen synthesis of the skin.
• Clinically recognized for its ability to manage eczema flares without the risk of skin thinning (atrophy) or striae.
• Specifically engineered to reduce the skin’s sensitivity to environmental triggers and allergens.
• Acts as a functional catalyst for healing in delicate regions where traditional steroids are contraindicated.
• Formulated in a specialized cream base that provides essential hydration while delivering the active constituent to the dermal layers.

Key Ingredients

• Pimecrolimus (1% w/w)
• Triglycerides
• Cetostearyl Alcohol
• Sodium Cetostearyl Sulphate
• Purified Sterile Water

Precautions

• Consult with a dermatologist prior to use; this medication is typically reserved for patients who have not responded to or cannot tolerate other topical therapies.
• Strictly for topical application. Avoid contact with the eyes, nostrils, and internal oral cavity.
• Limit exposure to natural or artificial sunlight during treatment, as immunomodulators may alter the skin’s response to UV radiation. Use of a broad-spectrum sunscreen is recommended.
• Do not apply to areas of the skin that are actively infected with viruses (e.g., herpes simplex, chickenpox) or bacteria.
• Use in pediatric patients must be strictly monitored and directed by a specialist familiar with topical calcineurin inhibitors.
• Keep the tube tightly closed and store in a cool, dry place (below 25°C). Do not freeze or expose to extreme heat.

How to Use

• Thoroughly wash and dry the affected area. Ensure the skin is clean and free from other topical residues before application.
• Apply a thin, uniform layer of Pacroma XL Cream to the affected areas of the skin.
• For optimal clinical results, apply twice daily—once in the morning and once in the evening—at the first sign of an eczema flare.
• Gently massage the cream into the skin until fully absorbed. Wash hands thoroughly after application unless the hands are being treated.
• Treatment should be discontinued once signs and symptoms of the flare have resolved. Consult your physician if symptoms persist beyond 6 weeks.
• Adherence to the prescribed application schedule is essential for achieving the long-term stabilization of the epidermal immune environment.

Legal Disclaimer: Pacroma XL Cream is a prescription-only medication. Individual results vary based on the severity of the dermatitis and the patient’s immune profile. This product is not intended for the treatment of Netherton’s Syndrome or severely immunocompromised patients. This information is for educational purposes and is not a substitute for professional medical consultation or a formal dermatological assessment.